Tag: Aortic Research Consortium

Complex TAAA: US ARC IDE registry reports better survival vs. real-world...

Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic...

US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR

The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair...